Last update 20 Mar 2025

Mesenchymal Stem Cell(Shandong Qilu Cell Therapy Engineering Technology)

Overview

Basic Info

Drug Type
Mesenchymal stem cell therapy
Synonyms-
Target-
Action-
Mechanism-
Therapeutic Areas
Congenital DisordersEndocrinology and Metabolic DiseaseUrogenital Diseases+ [4]
Active Indication-
Inactive Indication
Ascorbic Acid DeficiencyCOVID-19Familial Hypophosphatemic Rickets+ [1]
Originator Organization
Shandong Qilu Cell Therapy Engineering Technology Co., Ltd.Shandong Qilu Cell Therapy Engineering Technology Co., Ltd.
Active Organization-
Inactive Organization
Shandong Qilu Cell Therapy Engineering Technology Co., Ltd.Shandong Qilu Cell Therapy Engineering Technology Co., Ltd.
Drug Highest PhasePendingPhase 3
First Approval Date-
Regulation-
Login to view timeline

Related

4
Clinical Trials associated with Mesenchymal Stem Cell(Shandong Qilu Cell Therapy Engineering Technology)
IRCT20210307050611N1
/ RecruitingPhase 3
Mesenchymal stem cell injection in patients with knee osteoarthritis compared to a randomized controlled trial
JPRN-UMIN000053400
/ RecruitingNot ApplicableIIT
Prospective study of indoleamine 2,3-dioxygenase activity by mesenchymal stem cell in acute GVHD treatment - Prospective study of indoleamine 2,3-dioxygenase activity by mesenchymal stem cell in acute GVHD treatment
IRCT20200217046526N1
/ CompletedPhase 1/2
Mesenchymal Stem Cell Therapy for Acute Respiratory Distress Syndrome in Coronavirus Infection : A Phase 1 and 2 clinical trial
100 Clinical Results associated with Mesenchymal Stem Cell(Shandong Qilu Cell Therapy Engineering Technology)
Login to view more data
100 Translational Medicine associated with Mesenchymal Stem Cell(Shandong Qilu Cell Therapy Engineering Technology)
Login to view more data
100 Patents (Medical) associated with Mesenchymal Stem Cell(Shandong Qilu Cell Therapy Engineering Technology)
Login to view more data
100 Deals associated with Mesenchymal Stem Cell(Shandong Qilu Cell Therapy Engineering Technology)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Familial Hypophosphatemic RicketsPhase 3
China
Shandong Qilu Cell Therapy Engineering Technology Co., Ltd.Shandong Qilu Cell Therapy Engineering Technology Co., Ltd.
20 Jun 2021
Gitelman SyndromePhase 3
China
Shandong Qilu Cell Therapy Engineering Technology Co., Ltd.Shandong Qilu Cell Therapy Engineering Technology Co., Ltd.
20 Jun 2021
Ascorbic Acid DeficiencyPhase 3
China
Shandong Qilu Cell Therapy Engineering Technology Co., Ltd.Shandong Qilu Cell Therapy Engineering Technology Co., Ltd.
05 Feb 2020
COVID-19Phase 3
China
Shandong Qilu Cell Therapy Engineering Technology Co., Ltd.Shandong Qilu Cell Therapy Engineering Technology Co., Ltd.
05 Feb 2020
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free